MREO · CIK 0001719714 · operating
Mereo BioPharma Group plc (MREO) is a pharmaceutical preparations company incorporated in United Kingdom, listed on the Nasdaq. With a market capitalization of $63 million, Mereo BioPharma Group plc is a micro-cap company. The stock currently trades at $0.40, up 7.57% today, with a 52-week range of $0.20–$3.05.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.06 | $-0.06 | -50.0% | |
| 2023 | $-0.04 | $-0.04 | — |